rethinkPeptides Search
Menu
Study breakdown

Mitochondrial-Derived Peptides: How Your Mitochondria Signal Metabolic Protection

ReviewModerate evidence
The takeaway

Eight small peptides encoded by mitochondrial DNA act as metabolic stress sensors, with lower levels linked to obesity, diabetes, and aging, while treatment improves insulin sensitivity in rodents.

8 MDPs identified

Including humanin and MOTS-c, all showing metaboloprotective properties and links to metabolic disease

What the researchers found

Mitochondrial-derived peptides serve as retrograde metabolic signals — declining in metabolic disease but rising during adaptive stress responses like exercise — and can improve insulin sensitivity when administered therapeutically.

Why it matters

Understanding MDPs opens a new frontier in metabolic medicine — these peptides represent a built-in cellular signaling system that could be harnessed to treat diabetes, obesity, and age-related metabolic decline.

The numbers in context

8 MDPs; encoded in 12S and 16S rRNA genes; decreased in obesity, diabetes, aging; increased in exercising muscle; improved insulin sensitivity in rodents

How the study worked

Comprehensive review of human observational and rodent interventional studies on mitochondrial-derived peptides and their roles in energy metabolism.

Who was studied

Review of mitochondrial-derived peptide literature: humanin, MOTS-c, SHLP1-6 across metabolic conditions

What this study cannot tell us

Most therapeutic evidence is from rodent models; circulating MDP measurements in humans are still being standardized; tissue-specific responses are not fully characterized.

How to read the evidence

Strong mechanistic evidence with consistent findings across human observational and rodent interventional studies, but human clinical trials of MDP therapy are still needed.

When this study was published

Published in 2020; MDP research has accelerated since, particularly around MOTS-c and exercise metabolism.

The bigger picture

MDPs reveal that mitochondria are not just energy producers — they are active signaling hubs that communicate metabolic status throughout the body, fundamentally changing our understanding of cellular metabolism.

Questions still open

  • Can MDP supplementation effectively treat metabolic syndrome or type 2 diabetes in humans?
  • How do individual mitochondrial DNA variants affect MDP function across different populations?
  • What is the optimal therapeutic window for MDP-based interventions in aging?

Common questions

What are mitochondrial-derived peptides?
Small bioactive peptides encoded by mitochondrial DNA that signal metabolic status and provide protective effects against metabolic stress, aging, and disease.
Can mitochondrial peptides help with diabetes?
In rodent studies, humanin, MOTS-c, and SHLP2 improved insulin sensitivity and protected against metabolic disorders, though human clinical trials are still needed.

Read the original research

Mitochondrial-derived peptides in energy metabolism.

American journal of physiology. Endocrinology and metabolism, 319(4), E659-E666

Citation

Merry, Troy L; Chan, Alex; Woodhead, Jonathan S T; Reynolds, Joseph C; Kumagai, Hiroshi; Kim, Su-Jeong; Lee, Changhan. (2020). Mitochondrial-derived peptides in energy metabolism.. American journal of physiology. Endocrinology and metabolism, 319(4), E659-E666. https://doi.org/10.1152/ajpendo.00249.2020